These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 3936613)
1. Galactosyltransferase activities in cultured urinary bladder tumor cells. Gmeiner BM; Wolf G Cancer Biochem Biophys; 1985 Dec; 8(2):103-18. PubMed ID: 3936613 [TBL] [Abstract][Full Text] [Related]
2. Galactosyl transferase activity in rat bladder transitional cell carcinoma lines and in exfoliated cells in urine during carcinogenesis and reversible hyperplasia. Plotkin GM; Gilbert SL; Wides RJ; Wolf G; Cohen SM; Fukushima S Cancer Biochem Biophys; 1980; 4(4):251-6. PubMed ID: 6778604 [TBL] [Abstract][Full Text] [Related]
3. Comparison of cell-associated and soluble galactosyltransferase isoenzymes from a human bladder transitional cell carcinoma line. Gmeiner B; Wolf G Cancer Res; 1987 May; 47(9):2311-6. PubMed ID: 3105874 [TBL] [Abstract][Full Text] [Related]
4. Galactosyl transferase activity in human transitional cell carcinoma lines and in benign and neoplastic human bladder epithelium. Plotkin GM; Wides RJ; Gilbert SL; Wolf G; Hagen IK; Prout GR Cancer Res; 1979 Oct; 39(10):3856-60. PubMed ID: 476621 [TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295 [TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic activity of hypericin in human urinary bladder carcinoma cells. Kamuhabwa AR; Agostinis P; D'Hallewin MA; Kasran A; de Witte PA Anticancer Res; 2000; 20(4):2579-84. PubMed ID: 10953329 [TBL] [Abstract][Full Text] [Related]
8. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma. Gleave ME; Hsieh JT; Wu HC; Hong SJ; Zhau HE; Guthrie PD; Chung LW Cancer Res; 1993 Nov; 53(21):5300-7. PubMed ID: 8221665 [TBL] [Abstract][Full Text] [Related]
10. Connective tissue degradation by invasive rat bladder carcinomas: action of nonspecific proteinases on collagenous matrices. Pauli BU; Arsenis C; Hohberger LH; Schwartz DE Cancer Res; 1986 Apr; 46(4 Pt 2):2005-12. PubMed ID: 3004715 [TBL] [Abstract][Full Text] [Related]
11. Response of bladder carcinoma cells to TRAIL and antisense oligonucleotide, Bcl-2 or clusterin treatments. Sun B; Moibi JA; Mak A; Xiao Z; Roa W; Moore RB J Urol; 2009 Mar; 181(3):1361-71. PubMed ID: 19157446 [TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019 [TBL] [Abstract][Full Text] [Related]
13. An endogenous inhibitor of angiogenesis derived from a transitional cell carcinoma: clipped beta2-glycoprotein-I. Beecken WD; Engl T; Ringel EM; Camphausen K; Michaelis M; Jonas D; Folkman J; Shing Y; Blaheta RA Ann Surg Oncol; 2006 Sep; 13(9):1241-51. PubMed ID: 16955386 [TBL] [Abstract][Full Text] [Related]
14. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder. Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219 [TBL] [Abstract][Full Text] [Related]
15. The effect of antisense Bcl-2 oligonucleotides on Bcl-2 protein expression and apoptosis in human bladder transitional cell carcinoma. Duggan BJ; Maxwell P; Kelly JD; Canning P; Anderson NH; Keane PF; Johnston SR; Williamson KE J Urol; 2001 Sep; 166(3):1098-105. PubMed ID: 11490306 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of CA19-9 as a tumor marker in urothelial malignancy. Chuang CK; Liao SK Scand J Urol Nephrol; 2004; 38(5):359-65. PubMed ID: 15764245 [TBL] [Abstract][Full Text] [Related]
17. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder. Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407 [TBL] [Abstract][Full Text] [Related]
18. Blood group ABO-related glycosylation of urothelial cell lines: immunocytological, enzymatic, and genetic characterization. Meldgaard P; Holmes EH; Bennett EP; Clausen H; Zeuthen J; Wolf H; Orntoft TF Cancer Res; 1994 May; 54(9):2440-7. PubMed ID: 8162594 [TBL] [Abstract][Full Text] [Related]
19. Galactosyl transferase in benign and neoplastic human bladder mucosa. Hagen-Cook K; Prout GR; Plotkin GM; Gilbert SL; Wolf G Surg Forum; 1978; 29():627-9. PubMed ID: 122622 [No Abstract] [Full Text] [Related]
20. Characterization of alkaline phosphatase in human urinary bladder carcinoma cell lines and enzyme regulation with prednisolone or sodium chloride. Sorimachi K; Yasumura Y; Kakuya T Jpn J Exp Med; 1985 Oct; 55(5):185-92. PubMed ID: 3938823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]